Abstract
Ranolazine utilization in the management of refractory angina has been established by multiple randomized clinical studies. However, there is growing evidence showing an evolving role in the field of cardiac arrhythmias. Multiple experimental and clinical studies have evaluated the role of ranolazine in prevention and management of atrial fibrillation, with ongoing studies on its role in ventricular arrhythmias. In this review, we will discuss the pharmacological, experimental, and clinical evidence behind ranolazine use in the management of various cardiac arrhythmias.
| Original language | English |
|---|---|
| Pages (from-to) | 170-178 |
| Number of pages | 9 |
| Journal | Clinical Cardiology |
| Volume | 39 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1 2016 |
Bibliographical note
Publisher Copyright:© 2015 Wiley Periodicals, Inc.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Ranolazine in Cardiac Arrhythmia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver